These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 16752413

  • 1. Cancer proteomics and its application to discovery of therapy response markers in human cancer.
    Smith L, Lind MJ, Welham KJ, Cawkwell L, Cancer Biology Proteomics Group.
    Cancer; 2006 Jul 15; 107(2):232-41. PubMed ID: 16752413
    [Abstract] [Full Text] [Related]

  • 2. Recent advances in clinical oncoproteomics.
    Jain KK.
    J BUON; 2007 Sep 15; 12 Suppl 1():S31-8. PubMed ID: 17935275
    [Abstract] [Full Text] [Related]

  • 3. Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: current status.
    Hodgkinson VC, Eagle GL, Drew PJ, Lind MJ, Cawkwell L.
    Cancer Lett; 2010 Aug 01; 294(1):13-24. PubMed ID: 20176436
    [Abstract] [Full Text] [Related]

  • 4. Oncoproteomics: current trends and future perspectives.
    Cho WC, Cheng CH.
    Expert Rev Proteomics; 2007 Jun 01; 4(3):401-10. PubMed ID: 17552924
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Implications of salivary proteomics in drug discovery and development: a focus on cancer drug discovery.
    Hu S, Yen Y, Ann D, Wong DT.
    Drug Discov Today; 2007 Nov 01; 12(21-22):911-6. PubMed ID: 17993408
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Drug resistance in cancer - searching for mechanisms, markers and therapeutic agents.
    O'Connor R, Clynes M, Dowling P, O'Donovan N, O'Driscoll L.
    Expert Opin Drug Metab Toxicol; 2007 Dec 01; 3(6):805-17. PubMed ID: 18028026
    [Abstract] [Full Text] [Related]

  • 14. Proteomic approaches in lung cancer biomarker development.
    Cho JY, Sung HJ.
    Expert Rev Proteomics; 2009 Feb 01; 6(1):27-42. PubMed ID: 19210125
    [Abstract] [Full Text] [Related]

  • 15. Epithelial proteomics in multiple organs and tissues: similarities and variations between cells, organs, and diseases.
    Zhao H, Adler KB, Bai C, Tang F, Wang X.
    J Proteome Res; 2006 Apr 01; 5(4):743-55. PubMed ID: 16602680
    [Abstract] [Full Text] [Related]

  • 16. [Proteomics techniques and their application in haemato-oncologic malignancies].
    Zelená J, Hájek R.
    Cas Lek Cesk; 2007 Apr 01; 146(7):586-92. PubMed ID: 17722845
    [Abstract] [Full Text] [Related]

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 01; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 18. Clinical proteomics: discovery of cancer biomarkers using mass spectrometry and bioinformatics approaches--a prostate cancer perspective.
    Matharoo-Ball B, Ball G, Rees R.
    Vaccine; 2007 Sep 27; 25 Suppl 2():B110-21. PubMed ID: 17916461
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.